ArticleVaccines2021

Phase I Trial Evaluating the Safety and Immunogenicity of Candidate TB Vaccine MVA85A, Delivered by Aerosol to Healthy

Michael Riste et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.